COMPANY

Veroscience

HQ: Tiverton, RI source · veroscience.com ↗ · New England

Keywords: immunology metabolic disease of metabolism oncology type 2 diabetes mellitus metabolic syndrome Bromocriptine Cycloset

Location: Tiverton, RI · source · Oct 15, 2026

Profile checked Oct 10, 2026

Timeline

2014-01 Trial start Phase 1: Pharmacokinetic Study of CYCLOSET ® 0.8 mg Tablets in Children and Adolescent Type 2 Diabetes Mellitus Subjects source ↗
2005-02 Trial start Phase 3: Efficacy and Safety of Cycloset® Compared With Placebo When Added to Metformin source ↗
2004-07 Trial start Phase 3: Safety and Tolerability Study of Cycloset in Treatment of Type 2 Diabetes source ↗

Record	Title	Phase	Status	Start	Primary completion
NCT02078440	Pharmacokinetic Study of CYCLOSET ® 0.8 mg Tablets in Children and Adolescent Type 2 Diabetes Mellitus Subjects	Phase 1	Completed	2014-01	2016-06 (actual)
NCT00377676	Safety and Tolerability Study of Cycloset in Treatment of Type 2 Diabetes	Phase 3	Completed	2004-07	2007-01 (actual)
NCT00441363	Efficacy and Safety of Cycloset® Compared With Placebo When Added to Metformin	Phase 3	Terminated	2005-02	2006-02 (actual)